MediPal Holdings' market value is the price at which a share of MediPal Holdings trades on a public exchange. It measures the collective expectations of MediPal Holdings investors about its performance. MediPal Holdings is trading at 19.00 as of the 13th of February 2026. This is a No Change since the beginning of the trading day. The stock's lowest day price was 19.0. With this module, you can estimate the performance of a buy and hold strategy of MediPal Holdings and determine expected loss or profit from investing in MediPal Holdings over a given investment horizon. Check out MediPal Holdings Correlation, MediPal Holdings Volatility and MediPal Holdings Performance module to complement your research on MediPal Holdings.
Understanding that MediPal Holdings' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether MediPal Holdings represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, MediPal Holdings' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
MediPal Holdings 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to MediPal Holdings' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of MediPal Holdings.
0.00
11/15/2025
No Change 0.00
0.0
In 2 months and 31 days
02/13/2026
0.00
If you would invest 0.00 in MediPal Holdings on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding MediPal Holdings or generate 0.0% return on investment in MediPal Holdings over 90 days. MediPal Holdings is related to or competes with Shandong Weigao, Santen Pharmaceutical, Shandong Weigao, United Laboratories, Ansell, and Amplifon SpA. Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan More
MediPal Holdings Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure MediPal Holdings' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess MediPal Holdings upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for MediPal Holdings' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as MediPal Holdings' standard deviation. In reality, there are many statistical measures that can use MediPal Holdings historical prices to predict the future MediPal Holdings' volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of MediPal Holdings' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
MediPal Holdings appears to be not too volatile, given 3 months investment horizon. MediPal Holdings has Sharpe Ratio of 0.13, which conveys that the firm had a 0.13 % return per unit of risk over the last 3 months. We have found sixteen technical indicators for MediPal Holdings, which you can use to evaluate the volatility of the firm. Please exercise MediPal Holdings' Mean Deviation of 0.4522, risk adjusted performance of 0.1056, and Standard Deviation of 1.87 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, MediPal Holdings holds a performance score of 10. The company secures a Beta (Market Risk) of -0.32, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning MediPal Holdings are expected to decrease at a much lower rate. During the bear market, MediPal Holdings is likely to outperform the market. Please check MediPal Holdings' variance, as well as the relationship between the maximum drawdown and rate of daily change , to make a quick decision on whether MediPal Holdings' current price movements will revert.
Auto-correlation
0.00
No correlation between past and present
MediPal Holdings has no correlation between past and present. Overlapping area represents the amount of predictability between MediPal Holdings time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of MediPal Holdings price movement. The serial correlation of 0.0 indicates that just 0.0% of current MediPal Holdings price fluctuation can be explain by its past prices.
Other Information on Investing in MediPal Pink Sheet
MediPal Holdings financial ratios help investors to determine whether MediPal Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MediPal with respect to the benefits of owning MediPal Holdings security.